We know that most organisations are reassessing many things as they adapt to a new environment, shaped by uncertainty over the path to recovery for the UK economy, the ongoing unknowns in relation to COVID-19, how quickly they can adapt to new trading arrangements with the EU, and where they can identify new opportunities for growth.
Find out how we can helpPlayback of this video is not currently available
The pandemic forced many organisations to adapt at pace and this was certainly the case for those at the heart of developing and producing a viable vaccine. Over the past 18 months the pioneering work of AstraZeneca has thrust them into the spotlight and they suddenly became front page news. What was it like to have the eyes of the world on you, while maintaining the controls and transparency needed to retain trust?
In this episode, Philip Broadley, Senior Independent Non-Executive Director and Audit Committee Chair of AstraZeneca, joins PwC’s Head of Audit, Hemione Hudson, and host Teresa Owusu-Adjei. They discuss how disruption led to innovation in the face of a global crisis.
And looking towards the global challenge of combating climate change, what lessons can be learned about responding to a crisis at speed?
“If there is one thing that clients desire, it's the ability to trust you and help them work through their problems. At PwC, we are making a genuine commitment to help our clients get to a better place.”